Fresenius Kabi Makes Progress On Tocilizumab

Reports Positive Phase I Results For Actemra/Ro-Actemra Biosimilar

 
• By David Wallace
Tocilizumab injection Syringe
Fresenius Kabi’s MSB11456 tocilizumab candidate is moving ahead • Source: Alamy

More from Biosimilars

More from Products